Desreumaux, Pierre <br/><br/>
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.  [electronic resource] 

 -  Gastroenterology  Nov 2012 
 - 1207-1217.e2 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2012.07.116  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>C-Reactive Protein--metabolism<br/>Crohn Disease--blood<br/>Feces<br/>Female<br/>Humans<br/>Immunotherapy--adverse effects<br/>Leukocyte L1 Antigen Complex--metabolism<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Ovalbumin--immunology<br/>Quality of Life<br/>Severity of Illness Index<br/>Surveys and Questionnaires<br/>T-Lymphocytes, Regulatory--immunology<br/>Young Adult